May 28, 2019 - The 5th Cross-Consortia Newsletter features the latest advances and publications by the three Zika consortia. You will also learn about the launch of the European Clinical Research Alliance on Infectious Diseases (ECRAID), a new Zika vaccine ... Read more
May 22, 2019 - Apart from their direct impact, outbreaks also have on-going human, social and economic consequences, which can devastate fragile health systems in affected areas. Therefore, to ensure better local and global health, the need for expertise in ... Read more
April 18, 2019 - Registrations are now open for the 16th International Course on Dengue, Zika and Other Emergent Arboviruses to be held on August 12-23, 2019 at the Institute of Tropical Medicine “Pedro Kourí”, Havana, Cuba. Registration forms must ... Read more
March 27, 2019 - Scientists and technicians working on arbovirus projects in Brazil and across Latin America are meeting for a five-day training workshop organized by the Mérieux Foundation (ZikaPLAN) and Fundacao Faculdade de Medicina (ZIKAlliance) on March 25-29, 2019. Read more
March 6, 2019 - Resources include high-level justification for why engagement is important in an epidemic situation, as well as practical guides and tools on how to implement engagement activities in these circumstances. Read more
February 11, 2019 - The Birth Defect Surveillance Group, part of ZikaPLAN’s Work Package 8 (Disease Burden and Risk Assessment), announces the launch of the Global Birth Defects website. Read more
Eduardo Massad et al. – Epidemiology & Infection, May 16, 2019
In this study, the authors present a model to optimise a vaccination campaign aiming to prevent or to curb a Zika virus outbreak. In particular, they aim to determine the optimum time point to introduce a mass vaccination campaign in response to an outbreak, the thresholds to declare an outbreak, the optimum duration of such a strategy and the coverage needed to avert an outbreak.
Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.
To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.
Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).
ZikaPLAN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734584.